CHRONOPHARMACOLOGY OF ROFLUMILAST: A COMPARATIVE PHARMACOKINETIC STUDY OF MORNING VERSUS EVENING ADMINISTRATION IN HEALTHY ADULTS

REFERENCES

• Almeida L, Falcão A, Vaz-da-Silva M, Coelho R, Albino-Teixeira A, Soares-da-Silva P. (2008). Personality characteristics of volunteers in Phase 1 studies and likelihood of reporting adverse events. Int. J. Clin. Pharmacol. Ther. 46:340–348.
   PubMed Web of Science ®Google Scholar
• Altman LC, Munk Z, Seltzer J, Noonan N, Shingo S, Zhang J, Reiss TF. (1998). A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group. J. Allergy Clin. Immunol. 102:50–56.
   PubMed Web of Science ®Google Scholar
• Beam WR, Weiner DE, Martin RJ. (1992). Timing of prednisone and alterations of airways inflammation in nocturnal asthma. Am. Rev. Respir. Dis. 146:1524–1530.
   PubMedGoogle Scholar
• Bethke TD, Böhmer GM, Hermann R, Hauns B, Fux R, Mörike K, David M, Knoerzer D, Wurst W, Gleiter CH. (2007). Dose-proportional intraindividual single- and repeated-dose pharmacokinetics of roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor. J. Clin. Pharmacol. 47:26–36.
   PubMed Web of Science ®Google Scholar
• Bundschuh DS, Eltze M, Barsig J, Wollin L, Hatzelmann A, Beume R. (2001). In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor. J. Pharmacol. Exp. Ther. 297:280–290
   PubMed Web of Science ®Google Scholar
• Calverley PM, Lee A, Towse L, van Noord J, Witek TJ, Kelsen S. (2003). Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease. Thorax 58:855–860.
   PubMed Web of Science ®Google Scholar
• Calverley PM, Rabe KF, Goehring UM, Kristiansen S, Fabbri LM, Martinez FJ, M2-124 and M2-125 study groups. (2009). Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet 374:685–694.
   PubMed Web of Science ®Google Scholar
• Casale R, Pasqualetti P. (1997). Cosinor analysis of circadian peak expiratory flow variability in normal subjects, passive smokers, heavy smokers, patients with chronic obstructive pulmonary disease and patients with interstitial lung disease. Respiration 64:251–256.
   PubMed Web of Science ®Google Scholar
• D'Urzo A, Karpel JP, Busse WW, Boulet LP, Monahan ME, Lutsky B, Staudinger H. (2005). Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids. Curr. Med. Res. Opin. 21:1281–1289.
   PubMed Web of Science ®Google Scholar
• Fabbri LM, Calverley PM, Izquierdo-Alonso JL, Bundschuh DS, Brose M, Martinez FJ, Rabe KF, M2-127 and M2-128 study groups. (2009). Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials. Lancet 374:695–703.
   PubMed Web of Science ®Google Scholar
• Faurschou P, Engel AM, Haanaes OC. (1994). Salmeterol in two different doses in the treatment of nocturnal bronchial asthma poorly controlled by other therapies. Allergy 49:827–832.
   Google Scholar
• Goo RH, Moore JG, Greenberg E, Alazraki NP. (1987). Circadian variation in gastric emptying of meals in humans. Gastroenterology 93:515–518.
   PubMed Web of Science ®Google Scholar
• Hatzelmann A, Schudt C. (2001). Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro. J. Pharmacol. Exp. Ther. 297:267–279.
   PubMed Web of Science ®Google Scholar
• Hauns B, Huennemeyer A, Seiberling M, Zech R, Kuelzer R, Reuter F, Bethke D. (2003). Pharmacokinetics of roflumilast and roflumilast N-oxide in healthy subjects after a single, oral dose of 500 µg roflumilast in the morning vs evening. Eur. Respir. J. 22:102s. (Abstract P716)
   Google Scholar
• Hauns B, Hermann R, Hünnemeyer A, Herzog R, Hauschke D, Zech K, Bethke TD. (2006). Investigation of a potential food effect on the pharmacokinetics of roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, in healthy subjects. J. Clin. Pharmacol. 46:1146–1153.
   PubMed Web of Science ®Google Scholar
• Hetzel MR, Clark TJH. (1980). Comparison of normal and asthmatic circadian rhythms in peak expiratory flow rate. Thorax 35:732–738.
   PubMed Web of Science ®Google Scholar
• Huic M, Vrhovac B, Macolic-Sarinic V, Francetic I, Bakran I, Giljanovic S. (1996). How safe are bioequivalence studies in healthy volunteers? Thérapie 51:410–413.
   PubMedGoogle Scholar
• Kraft M, Hamid Q, Chrousos GP, Martin RJ, Leung DY. (2001). Decreased steroid responsiveness at night in nocturnal asthma. Is the macrophage responsible? Am. J. Respir. Crit. Care Med. 163:1219–1225.
   PubMed Web of Science ®Google Scholar
• Lemmer B. (1999). Chronopharmacokinetics: implications for drug treatment. J. Pharm. Pharmacol. 51:887–890.
   PubMed Web of Science ®Google Scholar
• Lemmer B. (2007). Chronobiology, drug-delivery, and chronotherapeutics. Adv. Drug Deliv. Rev. 59:825–827.
   PubMed Web of Science ®Google Scholar
• Lemmer B, Bruguerolle B. (1994). Chronopharmacokinetics. Are they clinically relevant? Clin. Pharmacokinet. 26:419–427.
   PubMed Web of Science ®Google Scholar
• Lemmer B, Nold G. (1991). Circadian changes in estimated hepatic blood flow in healthy subjects. Br. J. Clin. Pharmacol. 32:627–629.
   PubMed Web of Science ®Google Scholar
• Nisar M, Walshaw M, Earis JE, Pearson MG, Calverley PM. (1990). Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease. Thorax 45:190–194.
   PubMed Web of Science ®Google Scholar
• Pincus DJ, Szefler SJ, Ackerson LM, Martin RJ. (1995). Chronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efficacy. J. Allergy Clin. Immunol. 95:1172–1178.
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Touitou Y, Smolensky MH. (2008). Ethical and methodological standards for laboratory and medical biological rhythm research. Chronobiol. Int. 25:999–1016.
   PubMed Web of Science ®Google Scholar
• Postma DS, Koëter GH, vd Mark TW, Reig RP, Sluiter HJ. (1985). The effects of oral slow-release terbutaline on the circadian variation in spirometry and arterial blood gas levels in patients with chronic airflow obstruction. Chest 87:653–657.
   PubMed Web of Science ®Google Scholar
• Postma DS, Sevette C, Martinat Y, Schlösser N, Aumann J, Kafé H. (2001). Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening. Eur. Respir. J. 17:1083–1088.
   PubMed Web of Science ®Google Scholar
• Rodgers A, Bateman DN, Woodhouse KW. (1988). Is diurnal variation in absorption of slow-release aminophylline in the elderly an age-related phenomenon? Eur. J. Clin. Pharmacol. 33:593–597.
   PubMedGoogle Scholar
• Schuirmann DJ. (1987). A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J. Pharmacokinet. Biopharm. 15:657–680.
   PubMedGoogle Scholar
• Sibille M, Deigat N, Janin A, Kirkesseli S, Durand DV. (1998). Adverse events in phase-I studies: a report in 1015 healthy volunteers. Eur. J. Clin. Pharmacol. 54:13–20.
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Barnes PJ, Reinberg A, McGovern JP. (1986). Chronobiology and asthma. I. Day–night differences in bronchial patency and dyspnea and circadian rhythm dependencies. J. Asthma 23:321–343.
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Lemmer B, Reinberg AE. (2007). Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma. Adv. Drug Deliv. Rev. 59:852–882.
   PubMed Web of Science ®Google Scholar
• Steinijans VW, Hartmann M, Huber R, Radtke HW. (1991). Lack of pharmacokinetic interaction as an equivalence problem. Int. J. Clin. Pharmacol. Ther. Toxicol. 29:323–328.
   PubMedGoogle Scholar
• Turner-Warwick M. (1989). Nocturnal asthma: a study in general practice. J. R. Coll. Gen. Pract. 39:239–243.
   PubMedGoogle Scholar
• Weinbrenner A, Hüneke D, Zschiesche M, Engel G, Timmer W, Steinijans VW, Bethke T, Wurst W, Drollmann A, Kaatz HJ, Siegmund W. (2002). Circadian rhythm of serum cortisol after repeated inhalation of the new topical steroid ciclesonide. J. Clin. Endocrinol. Metab. 87:2160–2163.
   PubMed Web of Science ®Google Scholar